[Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
作者信息
Einecke Dirk
出版信息
MMW Fortschr Med. 2004 Jun 10;146(24):50.
PMID:15366495
Abstract
摘要
相似文献
1
[Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?].
MMW Fortschr Med. 2004 Jun 10;146(24):50.
2
[For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
MMW Fortschr Med. 2004 Jun 10;146(24):50.
3
[Clopidogrel protection is not increased further by ASS!].
Praxis (Bern 1994). 2004 Aug 25;93(35):1390.
4
Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19.
5
Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
Neurology. 2005 Apr 12;64(7):1117-21. doi: 10.1212/01.WNL.0000156357.50448.8A.
6
Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Int J Clin Pract. 2007 Oct;61(10):1739-48. doi: 10.1111/j.1742-1241.2007.01515.x.
7
The role of antiplatelet therapy in stroke prevention.
Tenn Med. 1997 Nov;90(11):454-5.
8
Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
Expert Rev Cardiovasc Ther. 2003 Nov;1(4):611-5. doi: 10.1586/14779072.1.4.611.
9
[High dosage acetylsalicylic acid administration for prevention of acute cerebral ischemia].
Nervenarzt. 1995 Dec;66(12):886-9; discussion 885.
10
Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
J Am Coll Cardiol. 2005 Sep 6;46(5):752-5. doi: 10.1016/j.jacc.2005.04.058.
Zotero 插件